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a  b  s  t  r  a  c  t
Health  data  are  used  for  still  more  purposes,  and policies  are  enacted  to facilitate  data reuse within
the  European  Union.  This  literature  synthesis  explores  attitudes  among  people  living  in the  European
Union  towards  the  use of  health  data  for purposes  other  than  treatment.  Our  ﬁndings  indicate  that  while
a  majority  hold  positive  attitudes  towards  the  use  of  health  data  for  multiple  purposes,  the  positiveeywords:
ealth data
nformed consent
ublic attitudes
eview
attitudes  are  typically  conditional  on the  expectation  that  data  will  be used  to further  the common  good.
Concerns  evolve  around  the  commercialisation  of data,  data  security  and  the  use  of data  against  the
interests  of the  people  providing  the  data. Studies  of  these  issues  are  limited  geographically  as  well  as
in scope.  We  therefore  identify  a  need  for  cross-national  exploration  of attitudes  among  people  living  in
the  European  Union  to inform  future  policies  in  health  data  governance.
ublis© 2019  The  Authors.  P
. Introduction
Personal health data are collected from patients on an unprece-
ented scale [1]. Data are used for a multitude of purposes,
ncluding research, planning, quality assurance and police work [2].
n some cases, data availability is also used by national governments
o attract international investments [3,4]. Health data are often
escribed as a “goldmine” with vast possibilities [5–7] and the Euro-
ean Commission has described health data as a unique resource
ue to the possibility of doing prospective as well as retrospec-
ive research at low costs [8]. OECD similarly encourages member
tates to develop and implement health data governance frame-
orks that secure privacy while also enabling the reuse of health
ata [1,9,10]. Correspondingly, the European Commission call on
ember states to invest in digital transformation of their health
ervices serving the double aim of improving population health and
trengthening the digital single market in Europe [11]. The Euro-
ean Council promotes adaptation of e-Health infrastructures to
acilitate accumulation, exchange and use of health data [12] and
he EU also promotes the FAIR principles to further enhance the
euse of research data by making them Findable, Accessible, Inter-
perable and Reusable [13]. With the adoption of the General Data
rotection Regulation (GDPR), the European Union (EU) has shown
ts commitment to promote data exchange within and between
∗ Corresponding author.
E-mail address: lsk@sund.ku.dk (L.L. Skovgaard).
ttps://doi.org/10.1016/j.healthpol.2019.03.012
168-8510/© 2019 The Authors. Published by Elsevier B.V. This is an open access article uhed  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
member countries while also increasing data protection [14]. In
short, policymakers across Europe are determined to ensure better
access to and increased use of health data for treatment as well as
other purposes.
Meanwhile, cases have developed in some European countries
demonstrating that the reuse of health data is a sensitive matter
that can develop into a publicly contested issue. In England, the col-
lection of data in the care.data scheme, where NHS Digital collected
health data from general practice to use for research and plan-
ning by actors within and outside NHS, caused a public controversy
[10,15]. In Denmark, a similar case, where health data collected
from general practice by a quality appraisal unit was  reused for
health research and administrative purposes, caused public reac-
tions [16]. In both cases, the legality of the databases and purposes
of data reuse were questioned in the public debate, which lead some
patients to request that their data were deleted. If public debate
causes some people to ask for withholding of health data, this indi-
cates a need to understand better under which conditions the use
of health data is seen as acceptable by people in the EU.  This is
important to ensure that governance is aligned with the views of
people in the EU member states - but also to ensure the validity of
the data recorded.
Previous reviews have suggested that people generally hold a
positive attitude towards the reuse of health data [17,18], but also
pointed to a lack of awareness about practices and patient rights
in relation to the sharing of health data [18]. Nevertheless, con-
cerns about privacy, conﬁdentiality and data security have also
been reported [17,18]. These reviews have been restricted either
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 1
Search Model.
Step 1: (lay perspective*) OR (lay view*) OR (lay attitude*) OR (lay opinion*)
OR  (lay preference*) OR (public perspective*) OR (public view*) OR (public
attitude*) OR (public opinion*) OR (public preference*) OR (patient
perspective*) OR (patient view*) OR (patient attitude*) OR (patient opinion*)
OR  (patient preference*)L.L. Skovgaard et al. / Hea
o studies using qualitative methods and have focused solely on
he reuse of health data for research purposes [17], or to attitudes
oward a speciﬁc data governance aspects such as informed con-
ent [18]. With this review, we update the understanding of public
ttitudes towards the reuse of health data focusing on the EU. We
mpose no methodological restrictions and include the reuse of data
or all purposes as well as all aspects of public opinion. Hence, the
im is to explore expressions of attitudes among people living in the
U towards the use of health data for purposes other than treatment.
Studies of attitudes often presuppose ideas about a uniform and
ounded group referred to as “the public”. It is, however, often
nclear who counts as members of this “public”. When studying
ttitudes a selection is taking place, e.g. based on assumptions
bout mental capability and age range, but these assumptions
ften remain implicit. Furthermore, these choices can have a polit-
cal character, for instance there are political disagreements about
hether unregistered migrants should be counted as part of the
ublic in a given country. In this way, the methodology of a study
onstructs its own public. In this article, we refer to people living
n the EU without imagining a bounded and exhaustive “public”
nd to avoid the impression of a uniform “public”. We  refer to
ealth data as data collected in relation to clinical care or other rou-
ine contacts to the healthcare sector, and understand the reuse of
ealth data as use for purposes beyond clinical care [19]. We  under-
tand views and attitudes as a normative predisposition arrived at
n the course of either qualitative inquiry or surveys that may,
ut need not, inform future action. They are nevertheless impor-
ant indicators of legitimacy. Attitudes are context dependent, and
ifferent methodologies will allow people to arrive at different
ositions.
. Methods
.1. Search strategy
Studies were identiﬁed through searches in the electronic
atabases Embase, PubMed, PsycInfo and Sociological Abstracts
uring 23rd–26th of August 2016 using free text searches and
he indexation system available in each database. The search was
pdated in January 2019. In addition, reference lists of obtained
iterature were reviewed and citation searches undertaken for the
ncluded studies (Web of Science). The search model can be seen in
able 1.
Fig. 1. In- and exclusAND
Step 2: (health data) OR (health record*) OR (electronic health record*) OR
(patient record*) OR (medical record*).
2.2. In- and exclusion criteria
Fig. 1 presents a ﬂow diagram of the in- and exclusion of studies.
Due to a technical challenge in the initial data search duplicates
were not removed before the initial screening of titles, but during
the screening of titles. However, this should have no practical effect
on the included studies.
[Author] screened all titles and abstracts for relevance. In cases
of doubt, [Author and Author] were consulted. The in- and exclusion
of studies followed the criteria listed in Table 2.
All studies underwent quality appraisal based on four basic
questions (Appendix 1 in Supplementary material) inspired by
Dixon-Woods et al. (2006) [23]. Due to the exploratory nature of
this review, the quality appraisal concerned basic levels of quality,
intern validity and relevance of the studies rather than a detailed
evaluation of potential biases. No studies were excluded due to poor
quality.
2.3. Data analysis
The review was  undertaken as a conﬁgurative literature syn-
thesis [24,25]. The included studies were coded for thematic
content using the software Nvivo. The coding followed an inductive
approach using line-by-line coding to let the themes emerge based
on the content of the texts [26]. Each study was  read by at least
two authors and coded by one author based on discussion with the
co-authors. Themes were discussed until agreement was  reached.
3. ResultsTwenty-nine studies were included (Fig. 1). An overview of
the articles, including author information, setting, methods, study
population and aims of the study, can be found in Table 3. The
majority of studies explored attitudes towards the use of health
ion of studies.
566 L.L. Skovgaard et al. / Health Policy 123 (2019) 564–571
Table  2
In- and exclusion criteria.
Criteria Description
Topic Studies that did not concern the views of people living in the EU on reuse of health data for purposes other than treatment were excluded.
Date  Studies published after 2000 were included.
Type of data Previous reviews have focused on attitudes towards the use of biological data [21,22]. This review focuses on attitudes towards the use of health
data  collected in conjunction with clinical care.
Peer review Only peer-reviewed literature was included to avoid inserting a bias as a result of grey literature being primarily published in local languages not
accessible to the authors.
Geography Studies from EU member states were included. Studies from the UK were included based on the expectation that some exchange of health data
between EU member states and the UK will continue despite UK leaving the union.
Language Studies that were accessible in English, German or the Scandinavian languages were included.
Duplicates In cases where several studies were conducted on the same dataset, only one study was included, unless the studies reported on different parts of
the  dataset or new analytical approaches were used.
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participation
Studies exploring patients’ views on the linkage of medical
as  these patients had already once agreed to their data bein
Study  design Reviews were not included but used to identify further prim
ata for research [17,18,27–44]. Most studies asked for views
egarding research in general [17,18,27–38,44], while six studies
ocused on speciﬁc registries [39–43,45]. Eight studies explored
iews on the use of data for purposes other than treatment and
esearch, namely the evaluation of a screening programme [46],
lanning and policy purposes [32,34,35,44], the production of per-
ormance reports [47] and quality assurance (clinical audit) [48].
ne study explored whom the participants would be willing to
rant access to their health data [49] and one study investigated
oncerns regarding access for non-medical personnel and private
ompanies [50]. The vast majority of studies were conducted in
he UK [17,18,27,31,33–37,39–45,47,48,51–53]. Six studies from
ther countries were identiﬁed, including Italy, Germany, Finland,
etherlands and Ireland [28–30,38,46,49] and one study was  a pan-
uropean survey [50].
.1. Low awareness
Generally, the studies reported low levels of awareness among
he respondents about the reuse of health data. Studies found lim-
ted awareness of speciﬁc disease registries [30,40], the existence
f a database from general practice [44], the content of the elec-
ronic health record (EHR) [28,48], anonymization practices [43],
ata sharing practices [17,31,37,48,49], the types of data used for
esearch and the types of research conducted [17]. Only two  studies
eported general awareness among the informants about the exis-
ence and content of the EHR [29,35]. The lack of awareness is an
mportant ﬁnding in itself and should be kept in mind, when other
esults are assessed.
.2. Positive attitudes conditioned on the perception that data
se serves the common good
The studies included in this review generally found positive
ttitudes among respondents towards the use of health data for
esearch purposes [30–32,41,44,45,53], the evaluation of a screen-
ng programme [46], quality assurance [48,50] and for planning and
olicy purposes [32,34,44]. Importantly, the positive attitudes seem
o be conditional on the understanding that the use of health data
ill further the common good [17,31,39,41,42,52,53], for example
hrough a better understanding of diseases [29,34,37], improve-
ent of treatments [34,53] or more efﬁcient health care planning
nd delivery [34,40].
.3. Unacceptable forms of data reuseHealth data reuse was seen as unacceptable when: 1) it was
erceived not to serve the common good, and 2) it was seen
s potentially conﬂicting with the interests of patients provid- records to data generated in a clinical trial they participated in were excluded
d for other purposes than treatment.
esearch.
ing the data. Concerning the ﬁrst, a common scepticism was
identiﬁed in relation to the commercialisation of health data
[42–44,49,52,53], either in the form of private companies proﬁt-
ing from data [17,42,49,53] or via the sale of health data to private
companies [42,52]. Some respondents, however, found the sale of
health data acceptable, as long as money is fed back into the public
health care services [36,52] and thereby used to further the com-
mon  good. Also, pharmaceutical companies having access to health
data was seen as positive by some [17,31,41] and negative by others
[17,36,39,41,50,53], depending on whom the respondents believed
would beneﬁt from the usage. Regarding the use of data to the
disadvantage of patients, concern was  expressed about employers
having access to health data [36,39] due to fear of negative implica-
tions for employment [29,52]. Furthermore, aversion towards the
sharing of health data with insurance companies was expressed in
several studies [31,33,34,36,37,41,44,45,48–50,52] because of fears
that data could be used to decline insurance claims or increase pre-
miums  [29,31,41,52]. Aversion towards health data being used for
marketing purposes was also expressed [39,52]. One study reported
scepticism among patients about the use of health data for the
publishing of performance information, because they found it to
be of limited use for their choice of provider [47]. A minority
appeared opposed to the use of health data irrespective of the pur-
pose [29,33]. In one study, a minority even expressed opposition to
let their own general practitioner (GP) view their general practice
medical records [33]. In another study, some patients stated that
they would only want to share anonymous data with their GP [29].
3.4. Sensitive data
Certain types of data appeared to be particularly sensitive for
some people to share. The perceived sensitivity of data seems
to depend on whether the information was  seen as potentially
stigmatising or the disclosure of data could have any other
adverse effects for the patients. Data on alcohol or substance use
[21], mental health (e.g. personal problems, depression, anxiety)
[29,36,37,41,51,52] or sexual health (e.g. lack of libido, erectile
dysfunction, contraception) [29,36,41,51,52] appeared to be par-
ticularly sensitive. One study also reported aversion among some
persons towards the sharing of information about ﬁnancial and
social issues (e.g. about life insurance and being laid off work) in a
national database [51].
3.5. Data security and data managementData security and data management practices were recurrent
themes in the studies. Some respondents expressed faith in data
security [17,37,39], but a majority of the studies found that peo-
ple generally worried about the security of data and feared data
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eakage [29,31,34–36,42,44,52]. Doubts were expressed about the
ompetencies and routines of those handling the data [17,42],
ncluding the adherence to guidelines for data management and
torage of data [17,29,31]. Though the effect of anonymization or
seudonymization was questioned by some [31,42,43], respon-
ents generally expressed a preference for data to be shared
nonymously for research, audit and policy-planning purposes
32,36,45,48]. Some people, however, doubted whether data were
able 3
verview of studies included in the review.licy 123 (2019) 564–571 567
anonymous and handled appropriately, and feared that privacy or
conﬁdentiality could be breached [37,42,43,52].
3.6. Requests for information about data reuseA desire to be better informed about which data were extracted
and for which purposes was also expressed in several studies
[17,30,34,41,45]. In two  studies, some respondents expressed the
568 L.L. Skovgaard et al. / Health Policy 123 (2019) 564–571
Table  3 (Continued)
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r even burdensome [31,37]. Those who requested information
ave various reasons for this, including the hope that it could
e beneﬁcial for their own treatment [31], that they wanted to
e able to make informed decisions about research participation
36,41,52,53], to avoid anxiety based on misconceptions of data use
37] or because giving information was seen as “common courtesy”
36,52].
.7. Attitudes towards informed consent
The majority of studies explored attitudes towards informed
onsent [27–31,33,35,37,38,39,41–43,45,46,52,53]. Some stud-
es sought to reveal preferences for different consent mod-
ls [28,30,37,39,41–43,45,52]. Others explored whether people
anted informed consent [27,33,38] and whether the anonymiza-
ion of data affected the preference for this [29,31,35,37,46,53].
able 4 presents an overview of different consent models presented
n the studies, along with stated attitudes towards the models. The
odels are not all mutually exclusive, but represent the choices
ffered in the respective studies.
For the use of health data for research, the share of respon-
ents who stated that consent should be sought before data are
sed varied between 12% [27] and 56% [38]. In the Finnish study,respondents were almost equally split between wanting consent
to be sought “every time”, “sometimes” and “never” for research
purposes [30]. If consent for the use of health data was to be legally
required, only 13.4% stated that they would prefer explicit con-
sent, while the rest would prefer some form of meta-consent (cf.
Table 4) [30]. In another study 10–11% of respondents wanted to
be asked, indicating a wish for explicit consent, if data was used to
inform audit and the publishing of performance information [48].
For teaching purposes, the percentage varied between 10% [27] and
44.3% [33]. Though one study made a distinction between consent
being sought always and in some cases only [30], none of the studies
informs us how often people think consent should be sought.
A majority of respondents stated that they would allow the
use of health data for research and quality assurance purposes
without consent, as long as data were anonymous [31,37,48,53],
while a minority appears to accept the use of identiﬁable health
data also without consent [48]. In one qualitative study, partici-
pants expressed preference for consent to be sought every time, if
anonymous or identiﬁable data were used for research [29]. When
identiﬁable data were used to evaluate a screening programme, the
vast majority also preferred consent to be sought [46]. Some studies
have explicitly investigated possible differences in patients’ pref-
erence for consent, depending on whether data are anonymous or
person identiﬁable, but they report contradicting attitudes [33,35].
L.L. Skovgaard et al. / Health Po
Table  4
Seven consent models found in the literature.
Consent model Attitudes toward consent model
Explicit consent
Consent is sought every time data
are used
13.4% preferred this model out of
four possible models (n = 423) [30].
The least preferred of four possible
consent models (n = 28) [52].
Dynamic consent
Patients can choose with whom
data will be shared. Patients can
change preferences at any given
time.
Patients appreciated the sense of
control given by dynamic consent
(n  = 40) [37].
Individual consent
Patients can choose different levels
of involvement (e.g. in anonymous
descriptive studies, clinical or
non-clinical research)
Patients found that being able to
choose levels of involvement
would encourage participation
(n = 68) [39].
Meta consent
1. One consent for one ﬁeld of
research
2.  One consent for one research
registry
1. 44.6% of respondents preferred
this model out of four possible
models (n = 423) [30]. 2. 41.3% of
respondents preferred this model
out of four possible models
(n = 423) [30].
Consent for Contact
Patients sign up for a registry and
allow researchers to contact
registered individuals if they meet
the criteria for a speciﬁc project
The frequency with which
participants would be contacted
seemed to be of importance for
attitude, though no acceptable
frequency was agreed upon (n = 37)
[41].
Consent agreement with GP
GPs act as ‘gate-keepers’ for
researchers’ access to patients’
health records. Consent is given
once to the GP.
83.7% of respondents would be
willing to let their GP
decide when to provide
anonymous information to
researchers (n = 1575) [28].
Opt out
Inclusion as default. Patients have
to actively let the relevant
authority know if they do not
want health data to be used.
Patients expressed dissatisfaction
with this model (3537 tweets from
904 twitter accounts) [43], (201
entries from 171 bloggers
Blog entries from 85 individuals on
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rtwo blogs from The Guardian) [42].
The most preferred model out of
four possible (n = 28) [52]
. Discussion
In this review, we have explored attitudes among people liv-
ng in the EU towards the reuse of health data. Only a few studies
onducted outside Britain was identiﬁed. This stresses a need for
urther empirical studies beyond the British context to be able to
ssess differences and similarities across various constituencies. A
ransnational study among EU member states, which include both
ualitative and quantitative methods, would secure accessibility of
nformation on opinions of people living in the EU about reuse of
ealth data beyond the local context.
Across the reviewed studies, it was striking that many respon-
ents did not know which health data were being shared and how
hey were being used. Hence, when interpreting the ﬁndings of the
tudies, it is important to bear in mind that patients expressed more
enerally formed attitudes without knowing the speciﬁcities of the
ractices involved. The studies included in this review do not pro-
ide possible explanations for the low levels of awareness which
arrants future studies to address this question. Many respondents
n the studies expressed a wish to be better informed about the stor-
ge and reuse of health data. Considering the fact that people are
sked to form an opinion about a topic that they have just stated
imited knowledge of, it is perhaps not surprising that they request
nformation.
Generally, the studies found that a majority of people hold pos-
tive attitudes towards the use of health data for purposes other
han treatment. However, some forms of data use require support
rom more than a simple majority: for registry studies to yield valid
esults researchers have pointed out that inclusion rates shouldlicy 123 (2019) 564–571 569
be at least 90% [46]. This raises a regulatory dilemma about how
autonomy should be weighed against the ability to produce valid
register research. In line with previous studies, we found that posi-
tive attitudes reported in the studies were often conditional on the
understanding that data would be used to further the common good
[17], and some respondents were opposed to the reuse of health
data when they believed this not to be the case. Hence, the purposes
of data use mattered to the respondents. For some people, pri-
vacy appeared to overrule all other concerns. Concerns expressed
in the studies particularly related to the fear that data might be
used to the disadvantage of patients (e.g. by insurance companies)
and that data would be commercialised leading to private com-
panies proﬁting from patients’ health data. It has previously been
suggested that citizens in the EU view medical information as sen-
sitive [54]. Our ﬁndings indicate that the perceived sensitivity of
data seems to depend on whether disclosure of the information is
viewed as stigmatising or potentially harmful to patients. Another
common concern was  that data would not be managed appropri-
ately and that data security was  insufﬁcient to prevent data leakage
or inappropriate access. These concerns stress the need for policy
makers to address issues relating to data management and data
security as it has also been pointed out by the EU (GDPR) and
OECD [10,14]. Regarding attitudes towards informed consent, no
clear picture of the legitimacy of various consent models emerged,
despite this issue being the focus of most studies. Given the vast
attention on informed consent it would be relevant for future stud-
ies to map  existing consent procedures across EU. It is worth noting
that informed consent did not appear to be an issue raised spon-
taneously by the respondents in the studies. Rather, the issue was
typically raised by the researchers who  asked informants directly
about whether they preferred consent and about their preferences
for speciﬁc consent models. Hence, the focus on consent might
reﬂect regulators and researchers’ interest in consent rather than
mirror the participants’ concerns [55]. Our point is not to argue for
or against informed consent but to draw attention to the fact that
the issue takes up so much space in the studies that it leaves lit-
tle room for discussion of other issues that are of clear importance
to patients, such as conditions of commercialization, data security,
and alternative forms of protection of patient interests. Consider-
ing the policy attentiveness to data protection and data security
[10,14], and the concerns expressed in the included studies, future
studies should address attitudes towards different ways of handling
data security to inform future policies.
Some variance in expressed attitudes was identiﬁed among the
studies. This may  reﬂect cultural differences among the countries
where the studies have been undertaken, but it may also reﬂect
methodological differences. The response rate being below 50% in
several studies [28–30,33,38,41,45] also introduces a risk of selec-
tion bias. Depending on the study population, some studies may  be
expected to elicit more positive attitudes than others, for example
when study participants are recruited from a patient involvement
group [52]. Likewise, more negative attitudes may  be expected
in, for instance, studies of online reactions to controversial cases
[42,43]. Contrary to our expectation, no systematic differences in
opinions were found in the studies from the UK before and after the
care.data case had unravelled. Concerning the risk that variance
across the studies is due to methodological differences, in par-
ticular framing should be considered. For example, Campbell and
colleagues (2007) asked people whether they would “prefer to give
[. . .]  permission” for “doctors” to access their health data in order to
“provide better information for the teaching of healthcare profes-
sionals” [27], whereas Ogden and colleagues (2005) asked patients
whether “medical students” should be “allowed to see” their “med-
ical record” and provided the options “never”, “only in emergency,
or at patient’s discretion” (i.e. explicit consent) or “whenever the
speciﬁed group wishes, or at the GP’s discretion” [33]. Answers to
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hese questions are difﬁcult to compare. The framing of the infor-
ation respondents are provided with might also affect attitudes.
hus, the possible effect of the nature of information given, for
xample the effects of limiting the information to positive impli-
ations for research [52] or negative effects of consent [18], should
e taken into account. Instead of viewing the variance as inconsis-
ency it could also be a manifestation of the fact that no single and
oherent public exists and that every public is always a construct
n a given situation [56]. This calls for experiments into how dif-
erent methodologies elicit different publics to understand better
hat we learn about public attitudes with different tools. Despite
hese limitations on comparability (and thereby accumulation of
ata from the different studies), we ﬁnd it remarkable that similar
oncerns were expressed in relation to the commercialisation of
ata, data security and the use of data against the interests of the
eople providing the data.
Grey literature was not included in the review, which can be
onsidered a limitation. However, it was excluded to avoid inserting
 bias as a result of grey literature being primarily published in local
anguages not accessible to the authors.
. Concluding remarks
Despite the general lack of awareness among respondents about
he reuse of health data, some tendencies did appear across the
tudies. The ﬁndings of this review suggest that the use of health
ata for purposes other than treatment enjoys support among peo-
le living in EU asked in these studies, as long as the data are
xpected to further the common good. Purposes anticipated to con-
ict with this included the commercialisation of data and the use
f data to potential disadvantage of patients. Concerned citizens do
mpact on the possibilities for using health data for purposes other
han treatment, as became evident in the cases in Denmark and
he UK, and the possible implications persist regardless of whether
oncerns are held by a representative part of the affected patients
r not. Considering the scepticism of commercial use of health data
dentiﬁed across the studies, current European policies on making
ata available for private companies [3,4,13,57–60] can involve a
isk of public backlash. Finally, studies of these issues outside the
K are very limited, suggesting a need for a studies, both quali-
ative and quantitative, among EU member states as well as new
ethodological experiments comparing different tools for explor-
ng attitudes in the same setting.
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